These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22928662)
1. Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies. Hack CE; Mannesse M; Baboeram A; Oortwijn B; Relan A BioDrugs; 2012 Oct; 26(5):303-13. PubMed ID: 22928662 [TBL] [Abstract][Full Text] [Related]
2. Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies. Hack CE; Relan A; Baboeram A; Oortwijn B; Versteeg S; van Ree R; Pijpstra R Clin Drug Investig; 2013 Apr; 33(4):275-81. PubMed ID: 23463274 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925 [TBL] [Abstract][Full Text] [Related]
6. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema. Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M; Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257 [TBL] [Abstract][Full Text] [Related]
8. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema. Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385 [TBL] [Abstract][Full Text] [Related]
9. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Varga L; Farkas H Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252 [TBL] [Abstract][Full Text] [Related]
10. Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk. van den Elzen MT; van Os-Medendorp H; Röckmann-Helmbach H; van Hoffen E; Lebens AF; van Doorn H; Klemans RJ; Bruijnzeel-Koomen CA; Hack CE; Kaufman L; Relan A; Knulst AC J Allergy Clin Immunol; 2016 Aug; 138(2):476-481.e1. PubMed ID: 27321437 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164 [TBL] [Abstract][Full Text] [Related]
12. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study. Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116 [TBL] [Abstract][Full Text] [Related]
14. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Bernstein JA; Relan A; Harper JR; Riedl M Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human c1 inhibitor (conestat alfa): in the treatment of angioedema attacks in hereditary angioedema. Plosker GL BioDrugs; 2012 Oct; 26(5):315-23. PubMed ID: 22946752 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Sabharwal G; Craig T Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442 [TBL] [Abstract][Full Text] [Related]
18. Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor. Farkas H; Varga L; Moldovan D; Obtulowicz K; Shirov T; Machnig T; Feuersenger H; Edelman J; Williams-Herman D; Rojavin M Ann Allergy Asthma Immunol; 2016 Nov; 117(5):508-513. PubMed ID: 27788880 [TBL] [Abstract][Full Text] [Related]
19. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema. Riedl M Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]